The Effect of EX1 Training in Normal Adults

February 27, 2023 updated by: Samsung Medical Center

The Effect of EX1 Training on Muscle Activity, Heart Rate, and Respiratory Metabolic Energy Consumption Rate in Normal Adults

In this study, when performing aerobic and anaerobic exercise with EX1 applied to normal adults between the ages of 19 and 65. The purpose of this study was to determine the effect on the muscle activity of the trunk and lower extremities compared with and without EX1.

Study Overview

Status

Completed

Detailed Description

In this study, aerobic exercise and anaerobic exercise for normal adults were divided into two visits for a total. For aerobic exercise, the investigators compared the aerobic treadmill walking program without EX1 [30 minutes of moderate (64-76% HRmax, 12-14 of RPE) aerobic treadmill walking, 40 minutes including warm-up and cool-down times], the aerobic treadmill walking program with EX1 [30 minutes of moderate (64-76% HRmax, 12-14 of RPE) aerobic treadmill walking, 40 minutes including warm-up and cool-down times] , and the high-intensity interval exercise (HIIT) program with EX1 [High-intensity-low-intensity interval walking exercise was performed at treadmill speed (High: 90-95% HRmax, 15-17 of RPE/Low: 60-70% HRmax, 9-11 of RPE) and EX1 resistance strength (High: resistance intensity 7- 9/Low: Resistance strength 0-2)] to check the effect on muscle activity, heart rate, and respiratory metabolic energy consumption rate.

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Normal adults aged 19 to 65 years

Description

Inclusion Criteria:

  • Healthy adults aged 19 to 65 years without a history of central nervous system disease

Exclusion Criteria:

  • Those who have difficulty walking independently due to problems such as visual field defects or fractures
  • Those who have difficulty understanding the exercise program due to severe cognitive decline (Korean-Mini-Mental State Examination, K-MMSE≤10)
  • Those who have difficulty participating in exercise programs due to adult diseases such as uncontrolled hypertension and diabetes
  • Those who are at risk of falling while walking due to severe dizziness
  • Those who are less than 140 cm or more than 185 cm in height that is not suitable size for the wearing of the walking assistance robot
  • Those who are overweight based on body mass index (BMI) 35 or higher

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Normal adults
aerobic and anaerobic exercises

[aerobic]

  1. Aerobic treadmill walking program without EX1
  2. Aerobic treadmill walking program with EX1
  3. High-intensity interval exercise (HIIT) program with EX1

[anaerobic]

1. Fitness exercise program with EX1

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduction on muscle activity (%MVC)
Time Frame: 3hours/2hours

[aerobic] All subjects underwent measurements of the trunk and lower extremity muscle activity (%MVC) during aerobic treadmill walking and measured by three conditions (①Aerobic treadmill walking program without EX1, ②Aerobic treadmill walking program with EX1, and ③High-intensity interval exercise (HIIT) program with EX1.

[anaerobic] All subjects underwent measurements of the trunk and lower extremity muscle activity (%MVC) during each condition

3hours/2hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduction on metabolic energy expenditure (ml·kg-1·min-1)
Time Frame: 3hours
[aerobic] All subjects underwent measurements of respiratory metabolism energy (ml·kg-1·min-1) during aerobic treadmill walking and measured by three conditions (①Aerobic treadmill walking program without EX1, ②Aerobic treadmill walking program with EX1, and ③High-intensity interval exercise (HIIT) program with EX1.
3hours
Reduction on heart rate (beats per minute, bpm)
Time Frame: 3hours
[aerobic] All subjects underwent measurements of heart rate (bpm) during aerobic treadmill walking and measured by three conditions (①Aerobic treadmill walking program without EX1, ②Aerobic treadmill walking program with EX1, and ③High-intensity interval exercise (HIIT) program with EX1.
3hours
Distinction on muscle activity (%MVC)
Time Frame: 3hours
[aerobic] Exercising with EX1 results in higher muscle activity than exercising without wearing EX1.
3hours
Distinction on metabolic energy expenditure (ml·kg-1·min-1)
Time Frame: 3hours
[aerobic] Exercising with EX1 consumes more energy for the same amount of time than exercising without wearing EX1.
3hours
Distinction on heart rate (beats per minute, bpm)
Time Frame: 3hours
[aerobic] Exercising with EX1 shows a higher heart rate for the same time than exercising without EX1.
3hours
Distinction on muscle activity (%MVC)
Time Frame: 2hours
[anaerobic] Fitness movements using EX1 generate more muscle activity than exercise without EX1.
2hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 23, 2022

Primary Completion (Actual)

December 28, 2022

Study Completion (Actual)

December 28, 2022

Study Registration Dates

First Submitted

February 6, 2022

First Submitted That Met QC Criteria

February 23, 2022

First Posted (Actual)

March 4, 2022

Study Record Updates

Last Update Posted (Actual)

March 1, 2023

Last Update Submitted That Met QC Criteria

February 27, 2023

Last Verified

January 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-12-153

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aerobic Exercises

Clinical Trials on aerobic and anaerobic exercises

Subscribe